Clinical trial · Observational
Registry for Advanced Endoscopy
Research Registry for Endoscopic Treatment and Diagnostics
NCT05187312CI-TRIAL-00075999ERDBrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Observational registry including endoscopic diagnostic and therapeutic interventions in the gastrointestinal tract
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cholangiocarcinoma | Cholangiocarcinoma | ONTOLOGY_EXACT | 0.98 |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
| Sclerosing Cholangitis | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endoscopic retrograde Cholangio- pancreatography | Procedure | — | UNRESOLVED |
| Endoscopic ultrasound | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Adverse events
- timeFrame
- 30-days and 60-days post-procedure
- description
- Incidence of Adverse events following endoscopic procedures. Measured as percentage of individuals with an adverse event
- measure
- Diagnostic yield
- timeFrame
- 1-year follow up
- description
- Diagnostic yield after tissue sampling
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical indication for endoscopic intervention/procedure Exclusion Criteria: * No informed consent * Age \<18 years
References
Publications (0)
Data not yet available
No reference posted for this study.